BioLife Plasma Services
Join Takeda as a Scientist, Process Analytics, Synthetic Molecule Process Development in Cambridge, MA, where you will provide specialized expertise in off-line analytical method development to support process chemistry and engineering efforts. This role involves designing and executing analytical activities for drug substance process development, troubleshooting process-related issues, and collaborating with cross-functional teams to optimize reactions and understand mechanisms for synthetic molecules. You will independently plan and execute unit operation characterization experiments while providing technical leadership within projects or complex studies.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Scientist Small Molecule SMDD
Eli Lilly and Company
Director, Synthetic Molecules Analytical R&D
AbbVie
Advisor - Analytical Chemistry
Eli Lilly and Company
Synthetic Molecule Design and Development (SMDD) Chemist
Lilly
Staff Synthetic Chemist
Par Health
Scientist - Analytical Method Development SMDD Foundry Readiness
Eli Lilly and Company